Table 5

Response of 2% ganciclovir eye drop compared with baseline 7 months–12 months

	n	Baseline	7 months	8 months	9 months	10 months	11 months	12 months
	n	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)	Median (min–max)
Visual acuity	9	0.2 (0–1.4)	0 (0–1.1)	0 (0–1.1)	0 (0–1.1)	0 (0–1.1)	0 (0–1.1)	0 (0–1.1)
			p = 0.017	p = 0.017	p = 0.017	p= 0.017	p= 0.017	p= 0.017
Cell	9	0.5 (0–4)	0 (0–1)	0 (0–1)	0 (0–0.5)	0 (0–0)	0 (0–0.5)	0 (0–0.5)
			p = 0.034	p = 0.008	p = 0.021	p= 0.008	p= 0.014	p= 0.008
IOP	9	28 (14–44)	14 (8–17)	12 (6–18)	12 (9–17)	15 (1–24)	14 (1–24)	12 (1–17)
			p = 0.013	p = 0.011	p = 0.008	p= 0.021	p= 0.018	p= 0.012
Antiglaucoma drug	9	3 (1–6)	1 (0–2)	1 (0–2)	1 (0–2)	1 (0–2)	0 (0–2)	0 (0–2)
			p = 0.011	p = 0.011	p = 0.011	p= 0.012	p= 0.007	p= 0.007
Steroid	9	4 (2–16)	0 (0–6)	0 (0–4)	0 (0–4)	0 (0–4)	0 (0–4)	0 (0–4)
			p = 0.024	p = 0.012	p = 0.012	p= 0.011	p= 0.016	p= 0.011
KPs present	9	10 (90.9%)	1 (11.11%)	0	1 (11.11%)	2 (22.22%)	2 (22.22%)	2 (22.22%)
			p = 0.016	NA	p = 0.016	p= 0.031	p= 0.031	p= 0.031

Wilcoxon Signed-rank test.
McNemar test.
Significant (p<0.05).
IOP, intraocular pressure; KPs, keratic precipitates.